newsfilter
← Latest News
FDA Approved Drugs·

Approval of Cibinqo, Nda #213871 (Labeling)

Approval Date: 09/02/2026; Drug Name: Cibinqo, Nda #213871; Active Ingredients: ABROCITINIB; Company: Pfizer; Submission Status: Approval; Submission Classification: Labeling; Application Number: 213871

Company
PFIZER
Keywords
PFIZER